• Explore /
  • Poster
  • / The adjuvant PANTHER study: A randomized comparison between dose-dense and tailored epirubicin (E), cyclophosphamide (C) and docetaxel (D) vs. standard dose 5-fluorouracil (F), epirubicin (E), cyclophosphamide (C) and docetaxel—Health-related quality of life during ongoing therapy.

The adjuvant PANTHER study: A randomized comparison between dose-dense and tailored epirubicin (E), cyclophosphamide (C) and docetaxel (D) vs. standard dose 5-fluorouracil (F), epirubicin (E), cyclophosphamide (C) and docetaxel—Health-related quality of life during ongoing therapy.

Abstract Poster

Authors

null

Yvonne Brandberg

Karolinska Institutet, Department of Oncology-Pathology (OnkPat), Karolinska University Hospital, Stockholm, Sweden

Yvonne Brandberg , Hemming Johansson , Mats Hellstrom , Theodoros Foukakis , Michael Gnant , Gunter von Minckwitz , Jonas C. S. Bergh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT00798070 ISRCTN ISRCTN39017665

Citation

J Clin Oncol 34, 2016 (suppl; abstr 1035)

DOI

10.1200/JCO.2016.34.15_suppl.1035

Abstract #

1035

Poster Bd #

140

Abstract Disclosures

Similar Posters

First Author: Vasilios Karavasilis

First Author: Theodoros Foukakis

First Author: Alexios Matikas

First Author: Christof Vulsteke